Dendritic Cell-Based Immunity: Screening of Dendritic Cell Subsets in Breast Cancer-Bearing Mice

[1]  Rupinder Kaur,et al.  Role of chemokines in breast cancer. , 2022, Cytokine.

[2]  Yu Cao,et al.  Artemisinin enhances the anti‐tumor immune response in 4T1 breast cancer cells in vitro and in vivo , 2019, International immunopharmacology.

[3]  M. Oliveira,et al.  Interferon-Gamma at the Crossroads of Tumor Immune Surveillance or Evasion , 2018, Front. Immunol..

[4]  B. Ruffell,et al.  Dendritic Cells and Cancer Immunity. , 2016, Trends in immunology.

[5]  N. McGovern,et al.  Unsupervised High-Dimensional Analysis Aligns Dendritic Cells across Tissues and Species , 2016, Immunity.

[6]  E. Murta,et al.  Phenotypic profile of dendritic and T cells in the lymph node of Balb/C mice with breast cancer submitted to dendritic cells immunotherapy. , 2016 .

[7]  Kebin Liu,et al.  An Orthotopic Mouse Model of Spontaneous Breast Cancer Metastasis. , 2016, Journal of visualized experiments : JoVE.

[8]  T. Kaisho,et al.  Critical Role for CD103(+)/CD141(+) Dendritic Cells Bearing CCR7 for Tumor Antigen Trafficking and Priming of T Cell Immunity in Melanoma. , 2016, Cancer cell.

[9]  R. Leighty,et al.  CD4+ T Cell Help Selectively Enhances High-Avidity Tumor Antigen-Specific CD8+ T Cells , 2015, The Journal of Immunology.

[10]  Boquan Jin,et al.  Type 1 regulatory T cells: a new mechanism of peripheral immune tolerance , 2015, Cellular and Molecular Immunology.

[11]  Kutlu G. Elpek,et al.  IgE/FcεRI-Mediated Antigen Cross-Presentation by Dendritic Cells Enhances Anti-Tumor Immune Responses. , 2015, Cell reports.

[12]  D. Sancho,et al.  Signalling versatility following self and non-self sensing by myeloid C-type lectin receptors. , 2015, Immunobiology.

[13]  S. Amigorena,et al.  Cross-Presentation in Mouse and Human Dendritic Cells. , 2015, Advances in immunology.

[14]  Sebastian Amigorena,et al.  Dissecting the tumor myeloid compartment reveals rare activating antigen-presenting cells critical for T cell immunity. , 2014, Cancer cell.

[15]  Wanjun Chen,et al.  The mucosal immune system in the oral cavity—an orchestra of T cell diversity , 2014, International Journal of Oral Science.

[16]  H. Boehmer.  The Thymus in Immunity and in Malignancy , 2014 .

[17]  P. Dessen,et al.  PD-L1 is a novel direct target of HIF-1α, and its blockade under hypoxia enhanced MDSC-mediated T cell activation , 2014, The Journal of experimental medicine.

[18]  D. Abdalla,et al.  Innate immune response adaptation in mice subjected to administration of DMBA and physical activity , 2013, Oncology letters.

[19]  Yusuke Nakamura,et al.  Identification of Promiscuous KIF20A Long Peptides Bearing Both CD4+ and CD8+ T-cell Epitopes: KIF20A-Specific CD4+ T-cell Immunity in Patients with Malignant Tumor , 2013, Clinical Cancer Research.

[20]  C. Sautès-Fridman,et al.  The immune contexture in human tumours: impact on clinical outcome , 2012, Nature Reviews Cancer.

[21]  Karolina Palucka,et al.  Cancer immunotherapy via dendritic cells , 2012, Nature Reviews Cancer.

[22]  E. F. Murta,et al.  The Role of T Lymphocytes in Cancer Patients Undergoing Immunotherapy with Autologous Dendritic Cells , 2011, Clinical Medicine Insights. Oncology.

[23]  A. Jemal,et al.  Global Cancer Statistics , 2011 .

[24]  H. Soliman.  Developing an effective breast cancer vaccine. , 2010, Cancer control : journal of the Moffitt Cancer Center.

[25]  D. Ingber,et al.  Tumor growth and angiogenesis are dependent on the presence of immature dendritic cells , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[26]  Lutz Weber,et al.  On the industrial applications of MCRs: molecular diversity in drug discovery and generic drug synthesis , 2010, Molecular Diversity.

[27]  H. Friess,et al.  Expression of the costimulatory molecule B7-H3 is associated with prolonged survival in human pancreatic cancer , 2009, BMC Cancer.

[28]  V. Appay,et al.  CD8+ T cell efficacy in vaccination and disease , 2008, Nature Medicine.

[29]  M. Del Vecchio,et al.  Interleukin-12: Biological Properties and Clinical Application , 2007, Clinical Cancer Research.

[30]  C. Boix,et al.  LPS induces rapid IL‐10 release by M‐CSF‐conditioned tolerogenic dendritic cell precursors , 2007, Journal of leukocyte biology.

[31]  K. Foulds,et al.  Th1 memory: implications for vaccine development , 2006, Immunological reviews.

[32]  L. Thompson,et al.  Human αβ and γδ Thymocyte Development: TCR Gene Rearrangements, Intracellular TCRβ Expression, and γδ Developmental Potential—Differences between Men and Mice12 , 2006, The Journal of Immunology.

[33]  H. Ljunggren,et al.  Escape from immune- and nonimmune-mediated tumor surveillance. , 2006, Seminars in cancer biology.

[34]  M. Girardi.  Immunosurveillance and Immunoregulation by γδ T Cells , 2006 .

[35]  N. Matsuda,et al.  Systemic inflammatory response syndrome (SIRS): molecular pathophysiology and gene therapy. , 2006, Journal of pharmacological sciences.

[36]  C. Hunter.  New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions , 2005, Nature Reviews Immunology.

[37]  G. Freeman,et al.  The B7 family revisited. , 2005, Annual review of immunology.

[38]  T. Watts,et al.  TNF/TNFR family members in costimulation of T cell responses. , 2005, Annual review of immunology.

[39]  D. Gabrilovich.  Mechanisms and functional significance of tumour-induced dendritic-cell defects , 2004, Nature Reviews Immunology.

[40]  J. Louis,et al.  The murine model of infection with Leishmania major and its importance for the deciphering of mechanisms underlying differences in Th cell differentiation in mice from different genetic backgrounds. , 2004, International journal for parasitology.

[41]  S. Henrickson,et al.  T-cell priming by dendritic cells in lymph nodes occurs in three distinct phases , 2004, Nature.

[42]  R. Jove,et al.  Hyperactivation of STAT3 Is Involved in Abnormal Differentiation of Dendritic Cells in Cancer , 2004, The Journal of Immunology.

[43]  Olivier Lantz,et al.  Dendritic Cell Maturation Controls Adhesion, Synapse Formation, and the Duration of the Interactions with Naive T Lymphocytes , 2004, The Journal of Immunology.

[44]  G. Pawelec.  Tumour escape: antitumour effectors too much of a good thing? , 2004, Cancer Immunology, Immunotherapy.

[45]  Li Li,et al.  Conversion of Peripheral CD4+CD25− Naive T Cells to CD4+CD25+ Regulatory T Cells by TGF-β Induction of Transcription Factor Foxp3 , 2003, The Journal of experimental medicine.

[46]  S. Hannier,et al.  Ixodes ricinus tick salivary gland extract inhibits IL‐10 secretion and CD69 expression by mitogen‐stimulated murine splenocytes and induces hyporesponsiveness in B lymphocytes , 2003, Parasite immunology.

[47]  Kenneth M. Murphy,et al.  Decision making in the immune system: The lineage decisions of helper T cells , 2002, Nature Reviews Immunology.

[48]  G. Freeman,et al.  The B7–CD28 superfamily , 2002, Nature Reviews Immunology.

[49]  Ira Mellman,et al.  Dendritic Cells Specialized and Regulated Antigen Processing Machines , 2001, Cell.

[50]  G. Zhu,et al.  B7-H1 costimulation preferentially enhances CD28-independent T-helper cell function. , 2001, Blood.

[51]  B. Spellberg,et al.  Type 1/Type 2 immunity in infectious diseases. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.